Table 2.
Half maximal inhibitory concentrations (IC50) of anti-cancer drugs in AMC-H1 and AMC-H2 primary HCC
| IC50(μM) | IC50ER | ||
|---|---|---|---|
| AMC-H1 | AMC-H2 | ||
| 5-FU | 2.05 | 1.71 | 1.198830409 |
| Cisplatin | 4.91 | 3.71 | 1.323450135 |
| Taxol | 0.125 | 0.127 | 0.984251969 |
| Sorafenib | 7.92 | 21.08 | 0.375711575 |
aIC50ER: IC50 with enhancement ratio (AMC-H1/AMC-H2)